drugset / Trial / NCT00543361

Study MK0767 and Metformin in Type 2 Diabetic Patients (0767-020)

NCT00543361

Phase 3 Terminated 382 enrolled Merck Sharp & Dohme LLC
RandomizedSingle-groupDouble-blindTreatment

Summary

The purpose of the study is to assess how MK0767, compared to Metformin, performs in lowering blood glucose levels in patients whose Type II diabetes is not controlled by diet and exercise.

Timeline

Start
2003-05
Primary completion
2003-12
Completion
2003-12

Drugs

EvaluationDrugModalityDoseRoute
Subject MK0767 Small molecule
Subject Metformin Small molecule